May 01, 2018 11:00 am UTC| Business
TORONTO, May 01, 2018 -- Tucows Inc. (NASDAQ:TCX) (TSX:TC) today announced that management will host a conference call on Wednesday, May 9, 2018 at 5:00 p.m. ET to discuss its first quarter 2018 financial results and...
eQuest Now Posts Jobs for the Majority of Top-Earning Companies in Europe
May 01, 2018 11:00 am UTC| Business
SAN RAMON, Calif., May 01, 2018 -- eQuest, the world’s largest job posting distribution company, today announced that it has officially secured the majority of companies featured in Wikipedia’s Largest European...
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
May 01, 2018 11:00 am UTC| Business
THE WOODLANDS, Texas, May 01, 2018 -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX) today announced that Lonnel Coats, President and Chief Executive Officer, will present at the following conference: Bank of America...
InspireMD Schedules First Quarter 2018 Earnings Conference Call
May 01, 2018 11:00 am UTC| Business
TEL AVIV, ISRAEL , May 01, 2018 -- InspireMD, Inc. (NYSE: NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that it will host a conference...
TeleTracking Names Christopher Johnson President
May 01, 2018 11:00 am UTC| Business
Pittsburgh, May 01, 2018 -- TeleTracking Chairman and CEO Michael Zamagias announced today that Christopher Johnson, Chief Solutions Officer, has been promoted to President. Effective immediately, Mr. Johnson will have...
Rescale And Remcom Bring NVIDIA GPU-Accelerated Electromagnetic Simulation To The Cloud
May 01, 2018 11:00 am UTC| Business
State College, PA, USA, May 01, 2018 -- Rescale and Remcom are pleased to announce that XFdtd®, Remcom’s electromagnetic (EM) simulation software, is now available on Rescale’s ScaleX platform for HPC in the cloud,...
G1 Therapeutics to Present at UBS Global Healthcare Conference in May 2018
May 01, 2018 11:00 am UTC| Business
RESEARCH TRIANGLE PARK, N.C., May 01, 2018 -- G1 Therapeutics, Inc. (Nasdaq:GTHX), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D., will present a company...